Évaluation de la qualité de vie (QDV) des patients tunisiens atteints de bronchopneumopathie chronique obstructive (BPCO)

Khalladi, Rania; Gargouri, I.; Mahjoub, Mohamed; Belhareth, S.; Saad, Helmi Ben

doi:10.1016/j.pneumo.2017.08.004

Cited by 5 publications

(2 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the present study, the COPD patients had almost the same profile observed in real practice in Tunisia (e.g., mean age, smoking habits, and corpulence status; Table 1 [Ben Moussa et al, 2014Ben Saad et al, 2008, 2014Khalladi et al, 2017;Rejeb et al, 2018]). For example, the mean age of the present study patients (66 ± 8 years) was similar to that of COPD patients included in two previous local studies (e.g., 63 ± 9 years [Ben Saad et al, 2008]; 60 ± 10 years [Khalladi et al, 2017]). Moreover, the mean age of this study's COPD patients and their smoking habits were intermediate compared with those reported in similar studies (Table S1).…”

Section: Discussion Of Methodologysupporting

confidence: 73%

How to Stage Airflow Limitation in Stable Chronic Obstructive Pulmonary Disease Male Patients?

et al. 2020

View full text Add to dashboard Cite

No study has evaluated the utility of different classifications of chronic obstructive pulmonary disease (COPD) airflow limitation (AFL) in terms of the refined “ABCD” classification of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) or in terms of the impacts on quality of life. This study aimed to compare some relevant health outcomes (i.e., GOLD classification and quality-of-life scores) between COPD patients having “light” and “severe” AFL according to five COPD AFL classifications. It was a cross-sectional prospective study including 55 stable COPD male patients. The COPD assessment test (CAT), the VQ11 quality-of-life questionnaire, a spirometry, and a bronchodilator test were performed. The patients were divided into GOLD “A/B” and “C/D.” The following five classifications of AFL severity, based on different post-bronchodilator forced expiratory volume in 1 s (FEV1) expressions, were applied: FEV1%pred: “light” (≥50), “severe” (<50); FEV1z-score: “light” (≥−3), “severe” (<−3); FEV1/height2: “light” (≥0.40), “severe” (<0.40); FEV1/height3: “light” (≥0.29), “severe” (<0.29); and FEV1Quotient: “light” (≥2.50), “severe” (<2.50). The percentages of the patients with “severe” AFL were significantly influenced by the applied classification of the AFL severity (89.1 [FEV1z-score], 63.6 [FEV1%pred], 41.8 [FEV1/height3], 40.0 [FEV1Quotient], and 25.4 [FEV1/height2]; Cochrane test = 91.49, df = 4). The CAT and VQ11 scores were significantly different between the patients having “light” and “severe” AFL. In GOLD “C/D” patients, only the FEV1Quotient was able to distinguish between the two AFL severities. To conclude, the five classifications of COPD AFL were not similar when compared with regard to some relevant health outcomes.

show abstract

Section: Discussion Of Methodologysupporting

confidence: 73%

How to Stage Airflow Limitation in Stable Chronic Obstructive Pulmonary Disease Male Patients?

et al. 2020

View full text Add to dashboard Cite

show abstract

“…The scale total score and the three subscales were scored on a 0 to 100 scale, where higher scores reflect worse health conditions [21,22]. The validity and reliability of the Arabic version of the SGRQ has been reported previously in patients with COPD [23][24][25].…”

Section: Upper Extremity Functional Index (Uefi)mentioning

confidence: 99%

The Upper Extremity Functional Index: Reliability and Validity in Patients with Chronic Obstructive Pulmonary Disease

Alnahdi

Albarrati

2021

IJERPH

View full text Add to dashboard Cite

The aim of the current study was to examine the psychometric properties of the upper extremity functional index (UEFI) in patients with chronic obstructive pulmonary disease (COPD). Seventy patients with stable COPD completed the UEFI and St. George Respiratory Questionnaire (SGRQ) and performed lung function tests in the first testing session. They completed the UEFI and the Global Rating of Change Scale in the second session, which was within ten days of the first session. The UEFI floor and ceiling effects, internal consistency, test–retest reliability, measurement error, and construct validity were examined. The UEFI was found to have no floor and ceiling effects. The UEFI was also found to have an excellent internal consistency (Cronbach’s alpha = 0.955) and an excellent test–retest reliability (ICC2,1 = 0.91). Totals of 4.85 points and 11.32 points represent the scale’s standard error of measurement, and a minimal detectable change at 90% confidence was used. The UEFI scores showed a significant correlation with the SGRQ activity domain (r = −0.66, p < 0.001) and differed significantly between participants with severe disease and those with mild disease (p = 0.03). The UEFI had no floor or ceiling issues, an excellent internal consistency, a good test–retest reliability, and an acceptable measurement error. The UEFI also demonstrated evidence supporting its construct validity as a measure of upper extremity-related activity limitations in patients with COPD.

show abstract

Évaluation de la version arabe du questionnaire français de qualité de vie « VQ11 » chez des patients tunisiens atteints de bronchopneumopathie chronique obstructive

Knaz

Anane

Guezguez

et al. 2020

Revue des Maladies Respiratoires

View full text Add to dashboard Cite

Évaluation de la qualité de vie (QDV) des patients tunisiens atteints de bronchopneumopathie chronique obstructive (BPCO)

Cited by 5 publications

References 33 publications

How to Stage Airflow Limitation in Stable Chronic Obstructive Pulmonary Disease Male Patients?

How to Stage Airflow Limitation in Stable Chronic Obstructive Pulmonary Disease Male Patients?

The Upper Extremity Functional Index: Reliability and Validity in Patients with Chronic Obstructive Pulmonary Disease

Évaluation de la version arabe du questionnaire français de qualité de vie « VQ11 » chez des patients tunisiens atteints de bronchopneumopathie chronique obstructive

Contact Info

Product

Resources

About